Population pharmacokinetics of fluconazole for prevention or treatment of invasive candidiasis in Chinese young infants. Publication Population pharmacokinetics of fluconazole for prevention or treatment of invasive candidiasis in Chinese young infants. Find out how gestational and postnatal age drive fluconazole PK variability; PopPK modelling supports tailored…CertaraJune 8, 2024
Clinical Pharmacology & Model-Informed Drug Development Insights for Targeted Radiation Therapies On-Demand Webinar Clinical Pharmacology & Model-Informed Drug Development Insights for Targeted Radiation Therapies Targeted radiation therapies (TRT) deliver cytotoxic radiation selectively to tumors. In recent years, oncology drug…CertaraMay 22, 2024
Reflections on the new FDA clinical pharmacology guidance for antibody-drug conjugates Blog Reflections on the new FDA clinical pharmacology guidance for antibody-drug conjugates In recent years, oncology drug developers have invested in antibody-drug conjugates (ADCs). These targeted therapies…CertaraMay 10, 2024
Comparative Bioequivalence and Food Effect of Two Formulations of 30-mg Nifedipine Controlled-Release Tablets in Healthy Chinese Adults Publication Comparative Bioequivalence and Food Effect of Two Formulations of 30-mg Nifedipine Controlled-Release Tablets in Healthy Chinese Adults Explore how nifedipine CR formulations are bioequivalent; food reduces exposure modestly, analysed using Phoenix WinNonlin.CertaraMarch 13, 2024
Population pharmacokinetic model for oral ORIN1001 in Chinese patients with advanced solid tumors Publication Population pharmacokinetic model for oral ORIN1001 in Chinese patients with advanced solid tumors Discover how PopPK modelling supports dose‑adjustment considerations for ORIN1001 based on bilirubin and lean body…CertaraMarch 4, 2024
Dose optimization considerations for targeted radiation therapies Blog Dose optimization considerations for targeted radiation therapies The acquisitions of targeted radiation therapy companies (TRT) Point Biopharma by Eli Lilly and RayzeBio…CertaraFebruary 16, 2024
Pharmacokinetic – toxicodynamic Modeling to Elucidate the Involvement of Dorsal Root Ganglion Neuron in Oxaliplatin – induced Peripheral Neurpathu Publication Pharmacokinetic – toxicodynamic Modeling to Elucidate the Involvement of Dorsal Root Ganglion Neuron in Oxaliplatin – induced Peripheral Neurpathu See how DRG‑based PK‑TD modelling predicts neuropathy severity and supports safer oxaliplatin dosing strategies using…CertaraFebruary 1, 2024
Comparative simulation of intraperitoneal aminoglycoside regimens for patients with peritonitis on automated peritoneal dialysis Publication Comparative simulation of intraperitoneal aminoglycoside regimens for patients with peritonitis on automated peritoneal dialysis Learn how both regimens achieve PK/PD targets; fixed‑dose regimen recommended with trough monitoring, modelled using…CertaraJanuary 30, 2024
The in vivo study on antioxidant activity of wendan decoction in treating hyperlipidemia: a pharmacokinetic-pharmacodynamic (PK-PD) model Publication The in vivo study on antioxidant activity of wendan decoction in treating hyperlipidemia: a pharmacokinetic-pharmacodynamic (PK-PD) model Find out how PK‑PD modelling shows delayed lipid‑lowering effects driven by key flavonoids in Wendan…CertaraJanuary 23, 2024
Population Pharmacokinetics and Individualized Medication of Azithromycin for Injection in Children Under 6 Years Old Publication Population Pharmacokinetics and Individualized Medication of Azithromycin for Injection in Children Under 6 Years Old Explore how weight and age drive azithromycin PK variability; PopPK modelling supports personalized dosing using…CertaraJanuary 20, 2024